LINKAGE GLOBAL INC (LGCB)

KYG5500B1023 - Common Stock

0.3699  +0.06 (+20.29%)

After market: 0.3555 -0.01 (-3.89%)

Fundamental Rating

3

LGCB gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 32 industry peers in the Broadline Retail industry. While LGCB seems to be doing ok healthwise, there are quite some concerns on its profitability. LGCB has a expensive valuation and it also scores bad on growth.



3

1. Profitability

1.1 Basic Checks

In the past year LGCB was profitable.
In the past year LGCB has reported a negative cash flow from operations.

1.2 Ratios

LGCB has a Return On Assets of 9.59%. This is amongst the best in the industry. LGCB outperforms 81.25% of its industry peers.
With a decent Return On Equity value of 22.39%, LGCB is doing good in the industry, outperforming 71.88% of the companies in the same industry.
The Return On Invested Capital of LGCB (11.74%) is better than 75.00% of its industry peers.
Industry RankSector Rank
ROA 9.59%
ROE 22.39%
ROIC 11.74%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

LGCB has a better Profit Margin (4.84%) than 65.63% of its industry peers.
The Operating Margin of LGCB (5.52%) is comparable to the rest of the industry.
With a Gross Margin value of 16.82%, LGCB is not doing good in the industry: 87.50% of the companies in the same industry are doing better.
Industry RankSector Rank
OM 5.52%
PM (TTM) 4.84%
GM 16.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

6

2. Health

2.1 Basic Checks

LGCB has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.

2.2 Solvency

LGCB has an Altman-Z score of 4.11. This indicates that LGCB is financially healthy and has little risk of bankruptcy at the moment.
LGCB has a better Altman-Z score (4.11) than 71.88% of its industry peers.
A Debt/Equity ratio of 0.38 indicates that LGCB is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.38, LGCB is in line with its industry, outperforming 46.88% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 4.11
ROIC/WACC2.4
WACC4.88%

2.3 Liquidity

LGCB has a Current Ratio of 2.59. This indicates that LGCB is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.59, LGCB belongs to the top of the industry, outperforming 84.38% of the companies in the same industry.
A Quick Ratio of 2.55 indicates that LGCB has no problem at all paying its short term obligations.
The Quick ratio of LGCB (2.55) is better than 93.75% of its industry peers.
Industry RankSector Rank
Current Ratio 2.59
Quick Ratio 2.55

0

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4.27%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.26%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 7.40, the valuation of LGCB can be described as very cheap.
84.38% of the companies in the same industry are more expensive than LGCB, based on the Price/Earnings ratio.
LGCB is valuated cheaply when we compare the Price/Earnings ratio to 27.73, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 7.4
Fwd PE N/A

4.2 Price Multiples

LGCB's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. LGCB is cheaper than 81.25% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.22

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

LGCB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LINKAGE GLOBAL INC

NASDAQ:LGCB (12/20/2024, 8:22:12 PM)

After market: 0.3555 -0.01 (-3.89%)

0.3699

+0.06 (+20.29%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners66.51%
Ins Owner ChangeN/A
Market Cap7.95M
AnalystsN/A
Price TargetN/A
Short Float %1.63%
Short Ratio0.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 7.4
Fwd PE N/A
P/S 0.36
P/FCF N/A
P/OCF N/A
P/B 1.67
P/tB 1.67
EV/EBITDA 5.22
EPS(TTM)0.05
EY13.52%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS1.02
BVpS0.22
TBVpS0.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.59%
ROE 22.39%
ROCE 16.06%
ROIC 11.74%
ROICexc 21.73%
ROICexgc 21.73%
OM 5.52%
PM (TTM) 4.84%
GM 16.82%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.98
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA 1.38
Cap/Depr 1.66%
Cap/Sales 0.01%
Interest Coverage 19.46
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.59
Quick Ratio 2.55
Altman-Z 4.11
F-ScoreN/A
WACC4.88%
ROIC/WACC2.4
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4.27%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.26%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A